Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acoustic Angiography in Breast and Thyroid Cancer
NCT04136912Phase 2Terminated
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- May 2022
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 cohorts), sponsored by UNC Lineberger Comprehensive Cancer Center. Primary endpoints: Sensitivity of Acoustic Angiography; Breast Imaging, Specificity of Acoustic Angiography; Breast Imaging and 2 more. Started May 2022; status: terminated.
Beyond the preview
Go deeper on NCT04136912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04136912.